Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States.

Artificial intelligence (AI) is increasingly reshaping diagnostic pathology, with breast pathology representing one of the most advanced and clinically impactful areas of adoption.

The integration of artificial intelligence (AI) into routine health-care applications has the potential to drive substantial advances across various medical fields, improving diagnostic precision, ...

Clinical adoption of digital pathology-based artificial intelligence models for diagnosing lung cancer has been limited, partly due to lack of robust external validation. This review provides an ...

Performance of an Artificial Intelligence Foundation Model for Prostate Radiotherapy Segmentation Patients who underwent initial consultation in a thoracic clinic between January 2019 and July 2023 ...

Proscia ® today introduced the Fifth Generation of its Concentriq ® 1 platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to ...

Over the past 50 years, multiple pathology organizations worldwide have evolved in cancer histopathology reporting from subjective, narrative assessments to structured, synoptic formats using ...